Matches in Wikidata for { <http://www.wikidata.org/entity/Q80446476> ?p ?o ?g. }
Showing items 1 to 63 of
63
with 100 items per page.
- Q80446476 description "artículu científicu espublizáu n'agostu de 2004" @default.
- Q80446476 description "scientific article published on 01 August 2004" @default.
- Q80446476 description "wetenschappelijk artikel" @default.
- Q80446476 description "наукова стаття, опублікована в серпні 2004" @default.
- Q80446476 name "Antecedent hypertension and the effect of captopril on the risk of adverse cardiovascular outcomes after acute myocardial infarction with left ventricular systolic dysfunction: Insights from the Survival and Ventricular Enlargement Trial" @default.
- Q80446476 name "Antecedent hypertension and the effect of captopril on the risk of adverse cardiovascular outcomes after acute myocardial infarction with left ventricular systolic dysfunction: Insights from the Survival and Ventricular Enlargement Trial" @default.
- Q80446476 type Item @default.
- Q80446476 label "Antecedent hypertension and the effect of captopril on the risk of adverse cardiovascular outcomes after acute myocardial infarction with left ventricular systolic dysfunction: Insights from the Survival and Ventricular Enlargement Trial" @default.
- Q80446476 label "Antecedent hypertension and the effect of captopril on the risk of adverse cardiovascular outcomes after acute myocardial infarction with left ventricular systolic dysfunction: Insights from the Survival and Ventricular Enlargement Trial" @default.
- Q80446476 prefLabel "Antecedent hypertension and the effect of captopril on the risk of adverse cardiovascular outcomes after acute myocardial infarction with left ventricular systolic dysfunction: Insights from the Survival and Ventricular Enlargement Trial" @default.
- Q80446476 prefLabel "Antecedent hypertension and the effect of captopril on the risk of adverse cardiovascular outcomes after acute myocardial infarction with left ventricular systolic dysfunction: Insights from the Survival and Ventricular Enlargement Trial" @default.
- Q80446476 P1433 Q80446476-DA82098E-72F0-4678-8ADE-5AF905C7D799 @default.
- Q80446476 P1476 Q80446476-2F355EF0-EA15-41E6-BFCA-CB9D4543E7BC @default.
- Q80446476 P2093 Q80446476-2A7A2625-EA98-46D0-89CD-A078BAF48CD1 @default.
- Q80446476 P2093 Q80446476-3A527056-2D9F-41E4-96BA-9432AE61F036 @default.
- Q80446476 P2093 Q80446476-56CA6F15-E3AC-49A1-835B-03A32BDD676F @default.
- Q80446476 P2093 Q80446476-7399849C-87C6-4CCB-A60E-87F47FF629F9 @default.
- Q80446476 P2093 Q80446476-7443BC2E-33DF-44D2-869E-CF586B1F5F33 @default.
- Q80446476 P2093 Q80446476-755AB423-DB72-43A8-9A3A-B9A3BDC956A1 @default.
- Q80446476 P2093 Q80446476-A426CD45-6D83-4551-BA75-4C37756E78DE @default.
- Q80446476 P2093 Q80446476-B3176639-857F-492E-983B-4C65DC288483 @default.
- Q80446476 P2093 Q80446476-C1020542-EDF9-45FC-9371-BCDE14FA7352 @default.
- Q80446476 P2093 Q80446476-F477D686-A3CD-4132-AEB3-B015FB072F00 @default.
- Q80446476 P304 Q80446476-0932C56B-8CC1-47BD-84EF-A6539EEB6BC9 @default.
- Q80446476 P31 Q80446476-AD71CBCF-95EE-48D8-B08E-44E504E0996A @default.
- Q80446476 P356 Q80446476-66E85846-9304-4003-AA7C-2FB84516B30B @default.
- Q80446476 P407 Q80446476-89639DFD-360B-41AF-BB71-12711C68CE0F @default.
- Q80446476 P433 Q80446476-62698741-E718-4920-8502-03CF2457E57E @default.
- Q80446476 P478 Q80446476-7D9DE084-72BB-4BBD-BC3B-037717DBB636 @default.
- Q80446476 P50 Q80446476-26635b46-4df9-53ab-1edf-79019e635620 @default.
- Q80446476 P50 Q80446476-68A2A598-8352-43F2-88D5-400F001A5E60 @default.
- Q80446476 P50 Q80446476-F6D0474A-B235-4CF6-BFF8-25E2C31D3A51 @default.
- Q80446476 P577 Q80446476-2D7AD2CA-0E9C-4D1A-994D-37A200DFC70A @default.
- Q80446476 P698 Q80446476-93781D17-9FB4-4338-8F93-C9626563EA15 @default.
- Q80446476 P921 Q80446476-1B33AF8B-D878-4226-BF16-A199502A417B @default.
- Q80446476 P921 Q80446476-26E5583B-3254-4BB4-823C-25DDFF3ECED1 @default.
- Q80446476 P356 J.AHJ.2004.02.011 @default.
- Q80446476 P698 15309009 @default.
- Q80446476 P1433 Q2227156 @default.
- Q80446476 P1476 "Antecedent hypertension and the effect of captopril on the risk of adverse cardiovascular outcomes after acute myocardial infarction with left ventricular systolic dysfunction: Insights from the Survival and Ventricular Enlargement Trial" @default.
- Q80446476 P2093 "Bruce Sussex" @default.
- Q80446476 P2093 "David Gordon" @default.
- Q80446476 P2093 "Edward J Brown" @default.
- Q80446476 P2093 "Eugene Braunwald" @default.
- Q80446476 P2093 "Gervasio A Lamas" @default.
- Q80446476 P2093 "Gilles R Dagenais" @default.
- Q80446476 P2093 "Marc A Pfeffer" @default.
- Q80446476 P2093 "Richard M Steingart" @default.
- Q80446476 P2093 "Survival and Ventricular Enlargement Trial" @default.
- Q80446476 P2093 "Victoria Bernstein" @default.
- Q80446476 P304 "356-364" @default.
- Q80446476 P31 Q13442814 @default.
- Q80446476 P356 "10.1016/J.AHJ.2004.02.011" @default.
- Q80446476 P407 Q1860 @default.
- Q80446476 P433 "2" @default.
- Q80446476 P478 "148" @default.
- Q80446476 P50 Q111842949 @default.
- Q80446476 P50 Q57331792 @default.
- Q80446476 P50 Q64684716 @default.
- Q80446476 P577 "2004-08-01T00:00:00Z" @default.
- Q80446476 P698 "15309009" @default.
- Q80446476 P921 Q18558122 @default.
- Q80446476 P921 Q496359 @default.